Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
21.90
+0.35 (1.62%)
Oct 24, 2025, 2:45 PM CST
SHE:300482 Revenue
Guangzhou Wondfo Biotech Co.,Ltd had revenue of 445.38M CNY in the quarter ending June 30, 2025, a decrease of -37.64%. This brings the company's revenue in the last twelve months to 2.74B, down -4.08% year-over-year. In the year 2024, Guangzhou Wondfo Biotech Co.,Ltd had annual revenue of 3.06B with 10.85% growth.
Revenue (ttm)
2.74B
Revenue Growth
-4.08%
P/S Ratio
3.72
Revenue / Employee
855.56K
Employees
3,197
Market Cap
10.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.06B | 299.90M | 10.85% |
| Dec 31, 2023 | 2.76B | -2.92B | -51.33% |
| Jan 1, 2023 | 5.68B | 2.32B | 69.01% |
| Dec 31, 2021 | 3.36B | 550.20M | 19.57% |
| Dec 31, 2020 | 2.81B | 738.52M | 35.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |
| Shanghai United Imaging Healthcare | 10.98B |